Wedbush analyst Jay McCanless has once again expressed confidence in Rithm Capital (NYSE:RITM), reiterating an Outperform rating and a $13...

GSK's groundbreaking gepotidacin, an innovative oral antibiotic, has unveiled exciting findings in the EAGLE-1 phase 3 trial focusing on uncomplicated...

On February 26, 2024, financial analyst Jade Rahmani from Keefe, Bruyette & Woods continues to support Newmark Group (NASDAQ:NMRK) with...

If an individual had invested $1000 in Centene (NYSE:CNC) stock a decade ago, it would now be valued at $5,124.36...

On February 26, 2024, Jade Rahmani, an analyst at Keefe, Bruyette & Woods, reaffirmed a Market Perform rating for Ares...

On February 26, 2024, Michael Cherny, an analyst at Leerink Partners, initiated coverage on Quest Diagnostics (NYSE: DGX) with a...

On February 26, 2024, Stifel analyst Stephen Gengaro affirmed a Hold rating for Lucid Group (NASDAQ: LCID) while adjusting the...

TPG revealed the pricing details for a secondary public offering of 15,526,915 shares of its Class A common stock on...

Amgen has broken ground on a state-of-the-art biomanufacturing facility in Central Ohio, specifically in New Albany. The newly named Amgen...

Iveda Solutions has recently been awarded a lucrative $3.2 million contract for a top-secret project by a government agency in...